Cargando…
Systemic Immunomodulatory Treatments for Patients With Atopic Dermatitis: A Systematic Review and Network Meta-analysis
IMPORTANCE: Most clinical trials assessing systemic immunomodulatory treatments for patients with atopic dermatitis are placebo-controlled. OBJECTIVE: To compare the effectiveness and safety of systemic immunomodulatory treatments for patients with atopic dermatitis in a systematic review and networ...
Autores principales: | Drucker, Aaron M., Ellis, Alexandra G., Bohdanowicz, Michal, Mashayekhi, Soudeh, Yiu, Zenas Z. N., Rochwerg, Bram, Di Giorgio, Sonya, Arents, Bernd W. M., Burton, Tim, Spuls, Phyllis I., Küster, Denise, Siegels, Doreen, Schmitt, Jochen, Flohr, Carsten |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7177646/ https://www.ncbi.nlm.nih.gov/pubmed/32320001 http://dx.doi.org/10.1001/jamadermatol.2020.0796 |
Ejemplares similares
-
Systemic Immunomodulatory Treatments for Atopic Dermatitis: Update of a Living Systematic Review and Network Meta-analysis
por: Drucker, Aaron M., et al.
Publicado: (2022) -
Systemic immunomodulatory treatments for atopic dermatitis: protocol for a systematic review with network meta-analysis
por: Drucker, Aaron Mark, et al.
Publicado: (2018) -
Status report on the atopic dermatitis registry TREATgermany
por: Siegels, Doreen, et al.
Publicado: (2021) -
Work ability and quality of working life in atopic dermatitis patients treated with dupilumab
por: Bosma, Angela L., et al.
Publicado: (2021) -
Use of systemic corticosteroids for atopic dermatitis: International Eczema Council consensus statement
por: Drucker, A.M., et al.
Publicado: (2018)